In this analysis of 3 case-control studies, the intake of nystose was associated with a higher risk of ovarian cancer, whereas the intake of 1F-β-fructofuranosylnystose was associated with a lower risk of ovarian cancer.
This Study Summary was published on October 16, 2024.
